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Adult  T  cell  leukemia  (ATL) 1 (1,  2),  associated  with  human  T  cell  leuke- 
mia/lymphoma virus (type I) (HTLV-I) (3), or ATL virus (ATLV) (4), is endemic 
to Japan,  the  Caribbean,  and  other  areas  (5).  Beside  integrating the  proviral 
DNA of HTLV, ATL cell lines continuously express an antigen (Tac antigen) 
(6) associated with the human interleukin  2  (IL-2) receptor (7-9),  the specific 
receptor for IL-2 (T cell growth factor) (10).  An abnormality in the regulation 
of this receptor was discovered (9)  when it was found that the Tac antigen on 
HTLV  + cells was not downregulated by anti-Tac monoclonal antibodies (mAb), 
whereas the same antigen on activated T  cells was downregulated by the anti- 
bodies (11 ). 
The striking association between the expression of Tac antigen and HTLV 
infection  led  us  to  the  question  of whether  the  abnormal  induction  of IL-2 
receptor  by  HTLV  infection is  unique  to  human  lymphoid tissues.  Here,  we 
report  that  the  IL-2  receptor  is constitutively expressed  not only in  HTLV  + 
human lymphoid cell lines, but also in rat cell lines transformed by HTLV-I (12). 
As was the case with human celt  lines transformed by HTLV-I,  these rat  cell 
lines were shown to be in the T  cell lineage, since they showed a rearrangement 
of the beta chain gene of the T  cell antigen receptor (13). In contrast to human 
HTLV  + T  cell lines reactive with anti-Tac antibodies (6), however, these HTLV  + 
rat  cell  lines  failed  to  react  with  anti-Tac  mAb.  Instead,  they  reacted  with 
antibodies against the rat IL-2 receptor (ART-18) (14,  15). These findings show 
that human as well as rat lymphoid cells transformed by HTLV constitutively 
express their own IL-2 receptor gene. The intimate relationship between HTLV 
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infection,  IL-2 receptor  gene  expression,  and  transformation  is  discussed  (16, 
17). 
Materials and  Methods 
Cells.  Three HTLV  ÷ rat lymphoid cell lines were obtained by cocultivating lymphoid 
cells of WKA/Hok rats with ATL cells from a typical ATL patient after first treating the 
ATL cells with 5-bromo-2'-deoxyuridine. TARS-1 and TART-1  cells were positive for 
the rat antigen Thy-l, whereas TARL-2 cells were negative (12).  MT-1  (18) and ATL-2 
cell lines (19) established from typical ATL patients were HTLV  ÷, and expressed the Tac 
antigen (19). 
Detection of T  Cell Antigen Receptor Gene and HTLV Provirus  Gene.  The presence of 
mouse T  cell antigen  receptor gene  was analysed using /3 chain complementary DNA 
(eDNA) (730 basepair Eco RI fragment of 86T5 [provided by Dr. M. M. Davis, Stanford 
University, Palo Alto, CA]) (13).  High molecular weight DNA (2 gg each) were digested 
with Eco RI and Bgl II, and fractionated by agarose gel electrophoresis. Southern blots 
of the  gels  were  hybridized  under  the  condition  described  previously (20)  with  nick- 
translated, 32P-labeled  ~ chain eDNA. The presence of the HTLV provirus genome was 
determined by a Southern blotting technique using DNA probes of the HTLV genome. 
Southern  blots  of the  gels  were  hybridized  with  the  nick-translated,  s~P-labeled  long 
terminal repeat sequences (LTR) (Sma I/Sac I, 456  basepairs), and gag (Sma I/Sma I, 
1,083 basepairs) probes of the HTLV/ATLV (21,  22). After hybridization, filters were 
washed in 0.1×  SSC (SSC  is 0.15  M NaCI in 0.015M  sodium citrate) and 0.1% sodium 
dodecyl sulfate (SDS) at 65 °C, and exposed for autoradiograph. 
'z5I-labeled IL-2.  E. coil-derived recombinant IL-2 (provided by Aji-nomoto Co., Ltd.) 
was labeled with 12~I using B.H. reagent (23). Effective radioactivity bindable to the ATL- 
2 cells that expressed IL-2 receptors was 25% of total activity. 
Scatchard  Plot Analysis  of IL-2 Receptor.  3  ×  108  cells were  incubated with  ~2"~IL-2 
(1,000 cpm/ng) at room temperature for 40 min. After washing three times in  1 ml of 
medium, by centrifugation at 1,200 rpm for 10 min, the cells were centrifuged at 10,000 
rpm for 3 rain on the layer of fetal calf serum. The radioactivity bound to the cells was 
counted by a gamma counter. Each value was calculated by subtracting nonspecific binding 
counts in the presence of a 500-fold excess of cold IL-2. 
Detection oflL-2 Receptor by Anti-lL-2 Receptor mAb.  5 ×  10  s cells were incubated with 
20 gl of appropriately diluted IgG fraction of anti-rat IL-2 receptor (ART-18) or anti- 
human  IL-2 receptor (anti-Tac) at 4°C for 30 min. After staining with fluoresceinated 
goat anti-mouse IgG (FITC-G/M) (Cappel Laboratories, Cochranville, PA) as the second 
antibody, the fluorescence intensity of the cells was analyzed by flow cytometry using a 
fluorescence-activated cell sorter (Becton Dickinson, Mountain View, CA). The data are 
given on a linear- or log-fluorescence scale. Positive fluorescence intensity was set so that 
three percent of the cells were positive when X5563 murine myeloma IgG2a was used as 
a negative control. 
SDS-polyacrylamide  Gel  Electrophoresis  (SDS-PAGE)  Analysis  with  Anti-IL-2  Recep- 
tor.  The cells were radiolabeled externally with  ~25I, lysed with the nonionic detergent 
Nonidet P-40 (NP-40), and immunoprecipitated with anti-Tac or ART18. The radiola- 
beled materials bound to protein A-Sepharose (PAS) beads were analyzed by SDS-PAGE 
in a 7.5% acrylamide gel, under reducing conditions. 5 ×  107 cells were suspended in pH 
8.0  phosphate buffered saline containing 20 mM glucose, and incubated with  10 IA of 
lactoperoxidase (2 mg/ml), 20 ~1 of glucose oxidase (10 U/ml), and 0.5 mCi l~5I-NaI (17.4 
Ci/mg; New England Nuclear, Boston, MA) for 30 min at room temperature. The cells 
were lysed in an extraction buffer (0.5% Nonidet P-40,  10 mM Tris-HCI, 0.15 M NaCI, 
1 mM phenylmethylsulfonyl fluoride, pH 7.5).  After preabsorption with PAS and Seph- 
arose beads conjugated with human Ig, the lysates were incubated overnight at 4°C with 
PAS and 5  ug/ml of either anti-Tac or ART-18 as an Ig fraction.  After washings,  the 
materials bound to the beads were eluted with SDS sample buffer and analyzed with SDS- 
PAGE (7.5% gel). 926  HTLV-PRODUCING  RAT  LYMPHOID CELL LINES 
Results 
Presence ofHTLVProvirus Genome.  The presence ofproviral DNA of HTLV-1 
in an HTLV  + rat cell line (TARS-l) was determined by Southern blot hybridi- 
zation using DNA fragments of pol, env, and pX sequences of HTLV. Both the 
TARS-1 cell line and leukemic cells in the peripheral blood of the ATL patient 
contained multiple copies of the viral genome. As shown in Fig. 1, they contained 
both complete and defective viral genomes. Although the data are not shown 
here, the genome of TARS-1 did not contain the human repetitive Alu sequence 
(24).  This result strongly suggests that there has been  no  transfer of human 
genome associated with the introduction of HTLV genome during the coculti- 
ration of rat spleen cells and ATL cells. 
Rearrangement  of T  cell Receptor Gene.  Since ATL is a  human leukemia of 
peripheral T cells, we analyzed the possible rearrangement of the T  cell receptor 
13 chain gene in these HTLV-I  + rat cell lines. DNA from these cell lines and from 
rat liver (germline control) were analyzed using a ~ chain DNA probe in Southern 
blot hybridization. As shown in Fig. 2, 13 chain genes were all rearranged in these 
rat cell lines compared with germline DNA. The loss of one of the two bands in 
these cell lines suggested that the 3' constant region gene was rearranged, while 
the 5'  constant region gene was deleted. The rearrangement appeared to be 
biallelic. Although we could not conclude whether the rearrangement was a VDJ 
FIGURE  l.  Proviral DNA of HTLV  in TARS-I  cells and peripheral blood lymphocytes of 
the ATL  patient that had been  used  for  the establishment of the rat cell  line.  DNA  were 
obtained from TARS-1  cells and the leukemic cells in peripheral blood of the ATL patient 
used  for  the  coculture  to  establish HTLV ÷ rat  cell  lines.  After  digestion  with  restriction 
enzymes, and electrophoresis in 0.5%  agarose gel, they were hybridized with LTR and gag 
probes. (A and B) Higb molecular weight DNA (2 #g each) from TARS-1 cell line; (C and D) 
High  molecular weight DNA fi-om the leukemic cells of the ATL patient.  Numbers on the 
left and right indicate sizes (in kilobases) of the hybridizing bands, based on the migration of 
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FIGURE 2.  Rearrangement of T cell receptor gene in HTLV-I  ÷ rat cell lines. DNA from rat 
liver, TARL-2, TART-l, and TARS-1 cells were digested with appropriate restriction enzymes 
and fractionated  by 0.7% agarose gel electrophoresis. Southern  blots of the gels were hybrid- 
ized with mouse 13 chain cDNA probe (86T5). Size marker is Hind III digest of ~ DNA. (A) 
Eco RI digestion; (B) Bgl II digestion; (lane a) rat liver; (lane b) TARL-2; (lane c) TART-l, 
(lane d) TARS-1. 
(variable-diversity-joining) recombination  or a  DJ  recombination,  the  data  sug- 
gested that these cell lines were in the T  cell lineage. 
Affinity oflL-2 Receptor for  125I-1L-2.  The  presence  of IL-2  receptor  of the 
TART-1 cell line was demonstrated by its binding with ~25I-IL-2. The association 
constant (K~), and the number of receptor sites were calculated from a Scatchard 
plot. The results are shown in Fig. 3. The results show that there are at least two 
different  levels of affinity for IL-2 receptor.  Receptors with a  high affinity for 
IL-2 have a  K~ of 1.3  ×  1011/M,  and those with  low affinity have a  Ka value of 
8.8 x  109/M. The number of receptor sites was also calculated using this analysis. 
There  are  1.8  ×  10 4  high  affinity  receptor  sites,  and  5.6  x  10 4  low  affinity 
receptor sites per cell.  TARS-1  and TARL-2  cell line cells also expressed -7.1 
x  103  and  7.8  x  103  IL-2 binding sites per cell, respectively, while the HTLV + 
human  T  cell  line,  ATL-2,  had  3.9  ×  105  IL-2 binding  sites per cell (data  not 
shown).  As expected,  there was no significant  IL-2 binding in  unstimulated  rat 
spleen cells. 
Detection of  lL-2 Receptor by Anti-IL-2 Receptor mAb.  To clarify whether a host 
IL-2 receptor was expressed in HTLV ÷ cell lines, the antigenic properties of IL- 
2 receptor on HTLV + rat and human T  cell lines were compared. The antigenic 
properties  of  IL-2  receptors  were  determined  by  mAb  recognizing  rat  IL-2 928  HTLV-PRODUCING  RAT  LYMPHOID  CELL  LINES 
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FIGURE 3.  Scatchard plot of TART-1.  (a) Binding curves of n~SI-labeled  IL-2 to TART-1 
(11). Total binding of IL-2 to TART-1; (0) specific binding; (A) nonspecific binding. Scatchard 
plot is calculated by these curves. (b) Scatchard plot. The K~ value for receptors with a  high 
affinity is 1.3 x  10n/M; the Ka for receptors with a low affinity is 8.8 x  109/M. The number 
of high affinity receptor sites is 1.8 x  104 per cell, and that of low affinity receptor is 5.6 x 
104 per cell. 
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FIGURE 4.  Expression of surface antigens associated with IL-2 receptor on rat and human T 
cell lines. HTLV + human ATL-2, rat TARS-1  T  cell lines, and HTLV- human MOLT-4 T 
cell lines were assessed for  the expression of antigens reactive with anti-rat IL-2  receptor 
(ART-18) and anti-human ILo2  receptor (anti-TaG). The fluorescence intensity higher than 
the vertical dashed line represents the positive labelling. The line is set so that a background 
nonspecific fluorescence with irrelevant x5563 IgG shows ~3% positivity. The proportion of 
positive cells is shown in as percent positive, while the mean fluorescnece intensity is shown in 
parentheses. The data is expressed in the log fluorescence scale. 
receptor (ART-18) and human I L-2 receptor (anti-TaG). As shown in Fig. 4, cells 
from the  HTLV + ATL-2 cell line expressed a  determinant reactive with anti- 
Tac antibody. There was no significant staining with either ART-18 or X5563 
mouse  Ig,  used  as  a  control,  confirming a  previous observation  that  the  IL-2 
receptor  on  human  HTLV +  cell  lines  does  not  react  with  ART-18  (14).  As 
expected,  the  HTLV-  MOLT-4  T  cell  line  failed  to  react  with  any  of the 
antibodies.  In  TARS-1  cells,  there  was  no  significant  staining  with  anti-TaG, 
despite  the  presence  of  IL-2  receptor,  as  detected  by  125I-IL-2  binding.  In 
contrast, >30%  of the cells were stained with ART-18.  As shown in Fig.  5, all 
three HTLV + rat T  cell lines were positive for ART-18, but not for anti-TaG, YODOI  ET  AL. 
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FIGUR~ 5.  The staining of three HTLV  ÷ rat cell lines with aiati-human and anti-rat IL-2 
receptor rnAb. (A) TARS-I; (B) TARL-2; (C) TART-l; (D) ATL-2. These cell line cells were 
stained with anti-Tac (a) and ART-18 (b), followed  by FITC-G/M antibodies. The fluorescence 
intensity is expressed in a linear fluorescence  scale. 
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proving  that the  IL-2  receptor  expressed  on  HTLV  + rat  T  cell  lines has  the 
antigenic determinant reactive with ART-18 but not with anti-Tac.  This result 
was  confirmed  by  the  finding  that  the  binding  of  ~25I-IL-2  to  these  cells  is 
inhibited by ART-18 but not by anti-Tac, whereas the binding to ATL-2 cells is 
inhibited by anti-Tac but not by ART-18 (not shown). 
Characterization of the IL-2 Receptor on TARS-1  Cells  by SDS-PAGE.  To com- 
pare the properties of the IL-2 receptor molecules expressed on human and rat 
HTLV  + cell lines, MT-1 cells and TARS-1 cells were internally labeled with [S~S]- 
methionine. Their IL-2 receptors  were immunoprecipitated with anti-Tac and 
ART-18, and characterized by SDS-PAGE analysis. As shown in Fig. 6, anti-Tac 
precipitated  60-65  kilodahon  (kD)  molecules from  MT-1  cell lysates, but not 
from lysates of TARS-1 cells. It is known (25) that the 60-65 kD band is obtained 
from normal T  cells, HTLV-, as well as HTLV  + human cell lines bearing IL-2 
receptor.  On  the other hand, ART-18  precipitated  50-55  kD molecules from 
TARS-l,  but  not  from  MT-I  cells.  The  size  of ART-18-reactive  molecules 
corresponds to the size of molecules from normal activated T  cells in rat (15). 
Discussion 
The expression of IL-2 receptor on rat cell lines transformed by HTLV-I was 
clearly demonstrated in our study by both the binding assay with ~25I-IL-2, and 
by flow cytometry with anti-IL-2 receptor mAb.  The results clearly show that 
HTLV infection induced IL-2 receptor expression on both human (7-9) and rat 
lymphoid cells. The analysis of the T  cell receptor/3 chain gene (Fig. 2) showed 
that these cell lines had a rearrangement in the 13 chain gene. The data suggested 
that these HTLV-I-transformed rat cell lines were in the T  cell lineage, despite 
the  fact that  one  of the cell  lines,  TARL-2,  had  been  lacking for any T  cell 
marker on the cell surface (12). 
It is generally known that HTLV  + human cell lines (6-9) express the human 
IL-2 receptor.  IL-2 receptor  is strongly expressed  in  ATL cells after a  short- 930  HTLV-PRODUCING  RAT  LYMPHOID  CELL  LINES 
FIGURE 6.  SDS-PAGE analysis of antigens on  rat  TARS-1  and human  MT-1  ceils trans- 
formed with HTLV/ATLV.  Lysates of TARS-1  (A) and MT-1  cells (B) were immunoprecipi- 
tated with anti-Tac; those of TARS-I  (C) and MT-1  cells (D) were immunoprecipitated with 
ART-18 antibodies. 
term incubation in vitro (8).  In such cases,  there are no gross abnormalities in 
the IL-2 receptor molecules, as determined by SDS-PAGE (25).  Functionally, 
however, the IL-2 receptor on the ATL-derived cell lines (MT-1  and Hut-102) 
have a significantly lower affinity for IL-2 than that of the receptors on HTLV- 
cell lines (our unpublished observations). However, TART-1 cells proved to have 
receptors with a high affinity for IL-2. 
Rat IL-2 receptor,  not human IL-2 receptor, was expressed on HTLV  + rat 
cell lines, as demonstrated by the fact that the IL-2 receptor on the rat cells does 
not react with anti-Tac, but does react with ART-18 (14). The collective evidence 
indicates that the IL-2 receptors on these cells are not the product of the extrinsic 
gene sequence transferred from human chromosomes during cocultivation with 
human ATL ceils.  It appears that HTLV infection is associated with the consti- 
tutive  expression  of a  host  gene  coding  for  IL-2  receptor,  regardless  of the 
species. Our results are quite consistent with the data using cDNA for recently YODOI  ET  AL.  931 
cloned human IL-2 receptor genes (26, 27). In ATL-derived cell lines expressing 
I L-2 receptor/Tac antigen, there was continuous transcription of the cellular IL- 
2 receptor gene. We have not detected any gross abnormality of the IL-2 receptor 
gene in ATL cell lines. 
The mechanism that leads to the expression of the host IL-2 receptor gene in 
HTLV  + lymphoid cell lines has not yet been elucidated. There are no common 
integration sites for HTLV, and the virus does not have typical oncogenes (20). 
One possible explanation is the trans-acting transcriptional activity of the HTLV- 
I genome, which may activate the transcription  of host genes, including the IL- 
2 receptor gene (28). On the other hand, it was recently found that many HTLV  ÷ 
human T  cell lines with helper phenotype produce a unique lymphokine, which 
enhances the synthesis and expression of human IL-2 receptor. The lymphokine, 
named ATL-derived factor (ADF) (19, 29), augmented the synthesis and expres- 
sion of the ART-18 antigen, associated with rat IL-2 receptor, on TARS-1 cells, 
across the  species barrier  (our unpublished  data).  It was also found that  ADF 
and  the  viral  proteins  having  trans-activating  effects (28) seemed to have ap- 
proximately the same molecular size, 40 kD. One may speculate that ADF may 
be related to the latter viral protein.  Alternatively,  the trans-activating  protein 
may activate the cellular ADF gene to produce ADF, which, in turn,  stimulates 
expression of the IL-2 receptor in susceptible cell lines. Indeed, our preliminary 
study indicated that ADF enhanced IL-2 receptor gene expression (unpublished). 
There  is no direct evidence yet that  IL-2 receptor plays a  role in the  leuke- 
mogenesis in  ATL.  Since the majority of HTLV  + cell  lines  neither  produce a 
significant amount of IL-2  (17) nor contain  messenger RNA for IL-2  (18),  an 
autocrine  mechanism  regulating  IL-2  does  not  seem  to  be  involved  in  the 
transformation in ATL. However, recent findings (30) of homology between the 
erb  B  oncogene  and  the  receptor  gene  for  epidermal  growth  factor  strongly 
suggest that an abnormally increased density of growth factor receptors, such as 
IL-2  receptor,  may play a  crucial  role  in  the  abnormal  proliferation  of cells. 
Using a  cDNA  probe  for  IL-2  receptor  gene,  the  analysis of the  constitutive 
expression of IL-2 receptor gene in ATL cell lines transformed by HTLV will 
be facilitated. 
Summary 
Three  rat  lymphoid cell  lines (TARS-I,  TARL-2,  and  TART-l)  (12) trans- 
formed by human  T  cell ieukemia/lympboma virus I (HTLV-I) had rearrange- 
ment of the j3 chain  gene  of the  T  cell  antigen  receptor,  and  had  integrated 
proviral  DNA from HTLV-I in their  genomes. As is the case with adult T  cell 
leukemia (ATL)-derived human T  cell lines transformed by HTLV-I, these rat 
cell  lines unequivocally expressed interleukin  2  (IL-2) receptor,  as determined 
by radiolabeled  IL-2 binding.  By Scatchard  plot analysis,  one of the cell  lines, 
TART-l, proved to have high affinity receptors (Ka =  1.3 X  101~/M  and 8.8 x 
109/M). Rat IL-2 receptor, not human IL-2 receptor, was expressed on HTLV  + 
rat cell lines, as demonstrated by the fact that they expressed antigens reactive 
with  monoclonai  antibodies  (ART-18) against  rat  IL-2  receptor,  but not  with 
anti-Tac antibodies. The collective evidence indicates that the endogenous IL-2 
receptor gene is activated in  human  and  rat  lymphoid cell  lines with  HTLV-I 932  HTLV-PRODUCING RAT  LYMPHOID  CELL  LINES 
production.  The  mechanism  of abnormal  IL-2  receptor  expression  in  HTLV 
infection is discussed. 
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